Funding for this research was provided by:
Virginia Commonwealth University (US) Massey Cancer Center (P30CA016059K)
National Center for Advancing Translational Science (1UL1TR002649)
Received: 2 January 2020
Accepted: 3 February 2020
First Online: 28 February 2020
Ethics approval and consent to participate
: This research involved human subjects and was performed in accordance with the Declaration of Helsinki. All participants provided informed consent. This study was approved by the Institutional Review Board of Virginia Commonwealth University.
: Not applicable.
: AA has served as a consultant for Astra Zeneca, Janssen, Merck, Novartis, Olatec, and Serpin pharma. BVT has served as a consultant for Novartis and Serpin Pharma.The remaining authors have nothing to disclose in regards to this study and no conflicts of interest exist for all listed authors.